RESISTANCE TO FEVER INDUCTION AND IMPAIRED ACUTE-PHASE RESPONSE IN INTERLEUKIN-1-BETA-DEFICIENT MICE

被引:320
作者
ZHENG, H
FLETCHER, D
KOZAK, W
JIANG, MH
HOFMANN, KJ
CONN, CA
SOSZYNSKI, D
GRABIEC, C
TRUMBAUER, ME
SHAW, A
KOSTURA, MJ
STEVENS, K
ROSEN, H
NORTH, RJ
CHEN, HY
TOCCI, MJ
KLUGER, MJ
VANDERPLOEG, LHT
机构
[1] MERCK RES LABS,DEPT IMMUNOL & INFLAMMAT,RAHWAY,NJ 07065
[2] MERCK RES LABS,LAB ANIM RESOURCES,RAHWAY,NJ 07065
[3] LOVELACE INST,INST BASIC & APPL MED RES,ALBUQUERQUE,NM 87108
[4] MERCK RES LABS,DEPT VIRUS & CELL BIOL,W POINT,PA 19486
[5] TRUDEAU INST INC,SARANAC LAKE,NY 12983
关键词
D O I
10.1016/1074-7613(95)90154-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used gene targeting in embryonic stem cells to introduce an IL-1 beta null allele in mice. The IL-1 beta-deficient mice develop normally and are apparently healthy and fertile. The IL-1 beta null mice responded normally in models of contact and delayed-type hypersensitivity or following bacterial endotoxin LPS-induced inflammation. The IL-1 beta-deficient mice showed equivalent resistance to Listeria monocytogenes compared with wild-type controls. In contrast, when challenged with turpentine, which causes localized inflammation and tissue injury, the IL-1 beta mutant mice exhibited an impaired acute-phase inflammatory response and were completely resistant to fever development and anorexia. These results highlight a central role for IL-1 beta as a pyrogen and a mediator of the acute-phase response in a subset of inflammatory disease models, and support the notion that blocking the action of a single key cytokine can alter the course of specific immune and inflammatory responses.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 63 条
  • [1] BIOLOGY OF MULTIFUNCTIONAL CYTOKINES - IL-6 AND RELATED MOLECULES (IL-1 AND TNF)
    AKIRA, S
    HIRANO, T
    TAGA, T
    KISHIMOTO, T
    [J]. FASEB JOURNAL, 1990, 4 (11) : 2860 - 2867
  • [2] A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION
    ALCAMI, A
    SMITH, GL
    [J]. CELL, 1992, 71 (01) : 153 - 167
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    [J]. ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 : 167 - 227
  • [4] ASHERSON GL, 1968, IMMUNOLOGY, V15, P405
  • [5] REGULATION OF MAJOR ACUTE-PHASE PLASMA-PROTEINS BY HEPATOCYTE-STIMULATING FACTORS OF HUMAN SQUAMOUS CARCINOMA-CELLS
    BAUMANN, H
    HILL, RE
    SAUDER, DN
    JAHREIS, GP
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 102 (02) : 370 - 383
  • [6] METABOLIC RESPONSE TO INFECTION
    BEISEL, WR
    [J]. ANNUAL REVIEW OF MEDICINE, 1975, 26 : 9 - 20
  • [7] INTERLEUKIN-1 IMMUNOREACTIVE INNERVATION OF THE HUMAN HYPOTHALAMUS
    BREDER, CD
    DINARELLO, CA
    SAPER, CB
    [J]. SCIENCE, 1988, 240 (4850) : 321 - 324
  • [8] BRODY DT, 1989, J IMMUNOL, V143, P1183
  • [9] PURIFICATION TO HOMOGENEITY AND AMINO-ACID SEQUENCE-ANALYSIS OF 2 ANIONIC SPECIES OF HUMAN INTERLEUKIN-1
    CAMERON, PM
    LIMJUCO, GA
    CHIN, J
    SILBERSTEIN, L
    SCHMIDT, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) : 237 - 250
  • [10] MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME
    CERRETTI, DP
    KOZLOSKY, CJ
    MOSLEY, B
    NELSON, N
    VANNESS, K
    GREENSTREET, TA
    MARCH, CJ
    KRONHEIM, SR
    DRUCK, T
    CANNIZZARO, LA
    HUEBNER, K
    BLACK, RA
    [J]. SCIENCE, 1992, 256 (5053) : 97 - 100